New Treatment Strategies for Dengue and Other Flaviviral Diseases (Novartis Foundation Symposia)

0 avg rating
( 0 ratings by Goodreads )
 
9780470016435: New Treatment Strategies for Dengue and Other Flaviviral Diseases (Novartis Foundation Symposia)

Dengue virus is a member of the Flaviviridae family, which includes viruses associated with human diseases such as yellow fever, Japanese encephalitis and hepatitis C. Dengue fever is transmitted by mosquitoes, principally Aedes aegypti. There are four serotypes of dengue virus, of which DENV-2 has been the most prevalent in many recent epidemics. Following primary infection, lifelong immunity develops, preventing repeated assault by the same serotype. However, the non-neutralizing antibodies from a previous infection or maternally acquired antibodies are thought to form complexes with a different serotype during a subsequent infection and cause dengue haemorrhagic fever/dengue shock syndrome, which can be fatal. There is no treatment or vaccine available today that can combat this emerging and uncontrolled disease.

This book features contributions from the world’s leading researchers working on dengue and related flaviviruses who examine the current state of the art in the molecular biology of the dengue virus. Particular emphasis is placed on the structure and function of the virus and the targeting of virus proteins by potential antiviral agents. The pathogenesis of dengue and dengue haemorrhagic fever are discussed in detail, especially the target cells and the specific receptors on these cells, thereby developing a clear overview of host and viral factors that contribute to dengue haemorrhagic fever. Finally, the book reviews the therapeutic options, paying particular attention to ways in which vector, host and environment can play a critical role in the spread of this disease.

With dengue fever and other emerging viral diseases becoming increasingly prevalent around the world, this book provides valuable insight into the virus that causes this disease and potential ways to manage it. It is essential reading for all those working in tropical diseases, public health and virology.

Praise from the reviews:

"The book provides an excellent summary of dengue/flavivirus research and is important for individuals and institutions interested in emerging infectious diseases." MICROBIOLOGY TODAY

"synopsis" may belong to another edition of this title.

About the Author:

The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.

Review:

"...this reviewer was highly moved by the painstaking investigations and careful evaluation of results by the participants of this symposium." (Journal of Tropical Pediatrics, February 2008)

"This is an excellent update of many aspects of dengue and the difficult quest for treatment and prevention. It is a valuable resource for new researchers coming to this fascinating field." (Doody's Health Services)

"...painstaking investigations and careful evaluation..." (Journal of Tropical Pediatrics, January 2007)

"...provides an excellent summary of dengue/flavivirus research and is important for individual and institutions interested in emerging infectious diseases."  (Microbiology Today, November 2007)

"...this reviewer was highly moved by the painstaking investigations and careful evaluation of results by the participants of this symposium." (Journal of Tropical Pediatrics, February 2008)

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 226.00
US$ 177.53

Convert Currency

Shipping: US$ 3.50
Within U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Novartis Foundation
Published by John Wiley and Sons
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Quantity Available: > 20
Seller:
INDOO
(Avenel, NJ, U.S.A.)
Rating
[?]

Book Description John Wiley and Sons. Book Condition: New. Brand New. Bookseller Inventory # 0470016434

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 177.53
Convert Currency

Add to Basket

Shipping: US$ 3.50
Within U.S.A.
Destination, Rates & Speeds

2.

Novartis Foundation
Published by John Wiley and Sons Ltd, United Kingdom (2006)
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Hardcover Quantity Available: 1
Seller:
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description John Wiley and Sons Ltd, United Kingdom, 2006. Hardback. Book Condition: New. Language: English . Brand New Book. Dengue virus is a member of the Flaviviridae family, which includes viruses associated with human diseases such as yellow fever, Japanese encephalitis and hepatitis C. Dengue fever is transmitted by mosquitoes, principally Aedes aegypti. There are four serotypes of dengue virus, of which DENV-2 has been the most prevalent in many recent epidemics. Following primary infection, lifelong immunity develops, preventing repeated assault by the same serotype. However, the non-neutralizing antibodies from a previous infection or maternally acquired antibodies are thought to form complexes with a different serotype during a subsequent infection and cause dengue haemorrhagic fever/dengue shock syndrome, which can be fatal. There is no treatment or vaccine available today that can combat this emerging and uncontrolled disease. This book features contributions from the world s leading researchers working on dengue and related flaviviruses who examine the current state of the art in the molecular biology of the dengue virus. Particular emphasis is placed on the structure and function of the virus and the targeting of virus proteins by potential antiviral agents. The pathogenesis of dengue and dengue haemorrhagic fever are discussed in detail, especially the target cells and the specific receptors on these cells, thereby developing a clear overview of host and viral factors that contribute to dengue haemorrhagic fever. Finally, the book reviews the therapeutic options, paying particular attention to ways in which vector, host and environment can play a critical role in the spread of this disease. With dengue fever and other emerging viral diseases becoming increasingly prevalent around the world, this book provides valuable insight into the virus that causes this disease and potential ways to manage it. It is essential reading for all those working in tropical diseases, public health and virology. Praise from the reviews: The book provides an excellent summary of dengue/flavivirus research and is important for individuals and institutions interested in emerging infectious diseases. MICROBIOLOGY TODAY. Bookseller Inventory # AAH9780470016435

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 186.58
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

3.

Novartis Foundation
Published by Wileyand#8211;Blackwell (2006)
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Quantity Available: 4
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Wileyand#8211;Blackwell, 2006. HRD. Book Condition: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Bookseller Inventory # FW-9780470016435

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 177.39
Convert Currency

Add to Basket

Shipping: US$ 11.98
From United Kingdom to U.S.A.
Destination, Rates & Speeds

4.

Novartis Foundation
Published by John Wiley and Sons Ltd, United Kingdom (2006)
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Hardcover Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description John Wiley and Sons Ltd, United Kingdom, 2006. Hardback. Book Condition: New. Language: English . Brand New Book. Dengue virus is a member of the Flaviviridae family, which includes viruses associated with human diseases such as yellow fever, Japanese encephalitis and hepatitis C. Dengue fever is transmitted by mosquitoes, principally Aedes aegypti. There are four serotypes of dengue virus, of which DENV-2 has been the most prevalent in many recent epidemics. Following primary infection, lifelong immunity develops, preventing repeated assault by the same serotype. However, the non-neutralizing antibodies from a previous infection or maternally acquired antibodies are thought to form complexes with a different serotype during a subsequent infection and cause dengue haemorrhagic fever/dengue shock syndrome, which can be fatal. There is no treatment or vaccine available today that can combat this emerging and uncontrolled disease. This book features contributions from the world s leading researchers working on dengue and related flaviviruses who examine the current state of the art in the molecular biology of the dengue virus. Particular emphasis is placed on the structure and function of the virus and the targeting of virus proteins by potential antiviral agents. The pathogenesis of dengue and dengue haemorrhagic fever are discussed in detail, especially the target cells and the specific receptors on these cells, thereby developing a clear overview of host and viral factors that contribute to dengue haemorrhagic fever. Finally, the book reviews the therapeutic options, paying particular attention to ways in which vector, host and environment can play a critical role in the spread of this disease. With dengue fever and other emerging viral diseases becoming increasingly prevalent around the world, this book provides valuable insight into the virus that causes this disease and potential ways to manage it. It is essential reading for all those working in tropical diseases, public health and virology. Praise from the reviews: The book provides an excellent summary of dengue/flavivirus research and is important for individuals and institutions interested in emerging infectious diseases. MICROBIOLOGY TODAY. Bookseller Inventory # AAH9780470016435

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 191.88
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Gregory R. Bock (editor), Jamie A. Goode (editor)
Published by Wiley 2006-08-25, Chichester (2006)
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Hardcover Quantity Available: 1
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Wiley 2006-08-25, Chichester, 2006. hardback. Book Condition: New. Bookseller Inventory # 9780470016435

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 198.71
Convert Currency

Add to Basket

Shipping: US$ 7.98
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Novartis Foundation
Published by John Wiley and Sons Ltd
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Hardcover Quantity Available: 4
Seller:
THE SAINT BOOKSTORE
(Southport, United Kingdom)
Rating
[?]

Book Description John Wiley and Sons Ltd. Hardback. Book Condition: new. BRAND NEW, New Treatment Strategies for Dengue and Other Flaviviral Diseases, Novartis Foundation, Dengue virus is a member of the Flaviviridae family, which includes viruses associated with human diseases such as yellow fever, Japanese encephalitis and hepatitis C. Dengue fever is transmitted by mosquitoes, principally Aedes aegypti. There are four serotypes of dengue virus, of which DENV-2 has been the most prevalent in many recent epidemics. Following primary infection, lifelong immunity develops, preventing repeated assault by the same serotype. However, the non-neutralizing antibodies from a previous infection or maternally acquired antibodies are thought to form complexes with a different serotype during a subsequent infection and cause dengue haemorrhagic fever/dengue shock syndrome, which can be fatal. There is no treatment or vaccine available today that can combat this emerging and uncontrolled disease. This book features contributions from the world's leading researchers working on dengue and related flaviviruses who examine the current state of the art in the molecular biology of the dengue virus. Particular emphasis is placed on the structure and function of the virus and the targeting of virus proteins by potential antiviral agents. The pathogenesis of dengue and dengue haemorrhagic fever are discussed in detail, especially the target cells and the specific receptors on these cells, thereby developing a clear overview of host and viral factors that contribute to dengue haemorrhagic fever. Finally, the book reviews the therapeutic options, paying particular attention to ways in which vector, host and environment can play a critical role in the spread of this disease. With dengue fever and other emerging viral diseases becoming increasingly prevalent around the world, this book provides valuable insight into the virus that causes this disease and potential ways to manage it. It is essential reading for all those working in tropical diseases, public health and virology. Praise from the reviews: "The book provides an excellent summary of dengue/flavivirus research and is important for individuals and institutions interested in emerging infectious diseases." MICROBIOLOGY TODAY. Bookseller Inventory # B9780470016435

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 205.58
Convert Currency

Add to Basket

Shipping: US$ 9.23
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

Novartis Foundation
Published by John Wiley and Sons Ltd, United Kingdom (2006)
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Hardcover Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description John Wiley and Sons Ltd, United Kingdom, 2006. Hardback. Book Condition: New. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. Dengue virus is a member of the Flaviviridae family, which includes viruses associated with human diseases such as yellow fever, Japanese encephalitis and hepatitis C. Dengue fever is transmitted by mosquitoes, principally Aedes aegypti. There are four serotypes of dengue virus, of which DENV-2 has been the most prevalent in many recent epidemics. Following primary infection, lifelong immunity develops, preventing repeated assault by the same serotype. However, the non-neutralizing antibodies from a previous infection or maternally acquired antibodies are thought to form complexes with a different serotype during a subsequent infection and cause dengue haemorrhagic fever/dengue shock syndrome, which can be fatal. There is no treatment or vaccine available today that can combat this emerging and uncontrolled disease. This book features contributions from the world s leading researchers working on dengue and related flaviviruses who examine the current state of the art in the molecular biology of the dengue virus. Particular emphasis is placed on the structure and function of the virus and the targeting of virus proteins by potential antiviral agents. The pathogenesis of dengue and dengue haemorrhagic fever are discussed in detail, especially the target cells and the specific receptors on these cells, thereby developing a clear overview of host and viral factors that contribute to dengue haemorrhagic fever. Finally, the book reviews the therapeutic options, paying particular attention to ways in which vector, host and environment can play a critical role in the spread of this disease. With dengue fever and other emerging viral diseases becoming increasingly prevalent around the world, this book provides valuable insight into the virus that causes this disease and potential ways to manage it. It is essential reading for all those working in tropical diseases, public health and virology. Praise from the reviews: The book provides an excellent summary of dengue/flavivirus research and is important for individuals and institutions interested in emerging infectious diseases. MICROBIOLOGY TODAY. Bookseller Inventory # BZV9780470016435

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 243.05
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

NOVARTIS FOUNDATION
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Hardcover Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description 2006. Hardback. Book Condition: NEW. 9780470016435 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Bookseller Inventory # HTANDREE0764281

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 233.82
Convert Currency

Add to Basket

Shipping: US$ 10.64
From United Kingdom to U.S.A.
Destination, Rates & Speeds

9.

Novartis Foundation (Corporate Author)
Published by John Wiley & Sons Inc (2006)
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Hardcover Quantity Available: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description John Wiley & Sons Inc, 2006. Hardcover. Book Condition: Brand New. 1st edition. 265 pages. 9.00x6.00x0.75 inches. In Stock. Bookseller Inventory # __0470016434

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 242.63
Convert Currency

Add to Basket

Shipping: US$ 7.98
From United Kingdom to U.S.A.
Destination, Rates & Speeds

10.

Published by Wiley (2006)
ISBN 10: 0470016434 ISBN 13: 9780470016435
New Hardcover First Edition Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Wiley, 2006. Hardcover. Book Condition: New. book. Bookseller Inventory # M0470016434

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 262.87
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds